Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models-Reference-Cited by-同舟云学术

Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models

Published:2022-03 Issue: Volume:46 Page:102267
ISSN:1477-8939
Container-title:Travel Medicine and Infectious Disease
language:en
Short-container-title:Travel Medicine and Infectious Disease

Author:

zhai Li-li,Wang Hui,Zhao Wei,Zhang Shou-feng,Miao Fa-ming,Cao Yang,Chen Chen,Li Yu-Feng,Gao Jie,Lv Ruo-yun,Zhang Shi-xiong,Cao Jia-bin,Zhang Xu-fan,Yang Ming-ming,Zhang Bin,Zhao Jing,Wei Jing-shuang^ORCID,Gao Jian

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference47 articles.

1. WHO expert consultation on rabies. Second report;World Health;World Health Organ Tech Rep Ser,2013

2. Current status of rabies and prospects for elimination;Fooks;Lancet,2014

3. Estimating the global burden of endemic canine rabies;Hampson;PLoS Neglected Trop Dis,2015

4. Estimating the global burden of endemic canine rabies;Hampson;PLoS Neglected Trop Dis,2015

5. Overview of the national epidemic situation of notifiable infectious diseases in China in 2020. Available online:https://www.cn-healthcare.com/article/20210312/content-552221.html.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

2. Preclinical animal models to evaluate therapeutic antiviral antibodies;Antiviral Research;2024-05

3. TO MARKET, TO MARKET–2022: MACROMOLECULAR THERAPEUTICS;Medicinal Chemistry Reviews;2023-11-16

4. Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial;International Journal of Infectious Diseases;2023-09

5. Pharmacokinetic study and preliminary evaluation of safety and efficacy of the recombinant human monoclonal antibodies against rabies virus (rhRIG) in Chinese healthy population: A randomized, single-blinded, placebo-controlled phase Ia clinical trial;Travel Medicine and Infectious Disease;2023-09